This receptor consists of 796 amino acids and can be divided in the extracellular ligand-binding domain, the trans-membrane domain, and the intracellular tyrosine kinase domain [1].This domain is the TMD of TrkA which has shown to be involved in the interaction with amyloid precursor protein (APP) [2]. [1]. 28039433. Structural characterization of nonactive site, TrkA-selective. kinase inhibitors.. Su HP, Rickert K, Burlein C, Narayan K, Bukhtiyarova M, Hurzy. DM, Stump CA, Zhang X, Reid J, Krasowska-Zoladek A, Tummala S,. Shipman JM, Kornienko M, Lemaire PA, Krosky D, Heller A, Achab. A, Chamberlin C, Saradjian P, Sauvagnat B, Yang X, Ziebell MR,. Nickbarg E, Sanders JM, Bilodeau MT, Carroll SS, Lumb KJ,. Soisson SM, Henze DA, Cooke AJ;. Proc Natl Acad Sci U S A. 2017;114:E297.. [2]. 28197073. Association of TrkA and APP Is Promoted by NGF and Reduced by. Cell Death-Promoting Agents.. Canu N, Pagano I, La Rosa LR, Pellegrino M, Ciotti MT, Mercanti. D, Moretti F, Sposato V, Triaca V, Petrella C, Maruyama IN, Levi. A, Calissano P;. Front Mol Neurosci. 2017;10:15. (from Pfam)
- Date:
- 2024-08-14